Background Chronic obstructive pulmonary disease (COPD) is characterized by chronic
inflammation in the small airways. The effect of inhaled corticosteroids (ICS) on lung …

Background Whether inhaled corticosteroids suppress airway inflammation in chronic
obstructive pulmonary disease (COPD) remains controversial. We sought to determine the …

Objective Inhaled corticosteroids (ICS) are generally used to treat patients with chronic
obstructive pulmonary disease (COPD) who suffer from repeated exacerbations. Recently, it …

Long-term treatment with inhaled corticosteroids (ICS) might attenuate lung function decline
and decrease airway inflammation in a subset of patients with chronic obstructive pulmonary …

Background: Several studies suggest that inhaled and oral corticosteroids repress systemic
inflammation in chronic obstructive pulmonary disease (COPD). However, the cytokines that …

Chronic obstructive pulmonary disease (COPD) is a chronic, inflammatory lung disease
characterized by airflow limitation that is not fully reversible. The pathological changes in …

Background: Whether all types of inhaled corticosteroids (ICSs) would increase the
pneumonia risk in patients with chronic obstructive pulmonary disease (COPD) remains …

Systemic and local inflammation is central to the pathophysiology of chronic obstructive
pulmonary disease (COPD). Increased levels of inflammation have been linked to a more …

PURPOSE: Although inhaled corticosteroids are commonly used to treat patients with
chronic obstructive pulmonary disease (COPD), their effect on clinical outcomes such as …

INTRODUCTION: The GOLD guidelines advocate not to institute inhaled corticosteroids
(ICS) in patients with mild-to-moderate COPD. However, many patients do use ICS and in …